Finance

Lists
A:NYSE
Agilent Technologies Inc
170,54 US$
+1,41%
(+2,37) 1D
170,54 US$
0,00% (0,00)
After hours
Closed: 9 ოქტ, 16:01:42 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for A...
Open
168,57 US$
High
172,19 US$
Low
168,57 US$
Mkt. cap
48,08 მლრდ.
Avg. vol.
2,51 მლნ.
Volume
1,54 მლნ.
Dividend
0,60%
Quarterly dividend
0,26 US$
Ex-dividend date
6 ოქტ. 2026
P/E ratio
33,61
52-wk high
177,05 US$
52-wk low
108,35 US$
EPS
5,07 US$
Beta
1,21
Shares outstanding
281,93 მლნ.
No. of employees
18 ათ.
Open
168,57 US$
High
172,19 US$
Low
168,57 US$
Mkt. cap
48,08 მლრდ.
Avg. vol.
2,51 მლნ.
Volume
1,54 მლნ.
Dividend
0,60%
Quarterly dividend
0,26 US$
Ex-dividend date
6 ოქტ. 2026
P/E ratio
33,61
52-wk high
177,05 US$
52-wk low
108,35 US$
EPS
5,07 US$
Beta
1,21
Shares outstanding
281,93 მლნ.
No. of employees
18 ათ.
News stories
From web sources and news partners
Profile
Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting initial public offering of Agilent stock was the largest in the history of Silicon Valley at the time. From 1999 to 2014, the company produced optics, semiconductors, EDA software and test and measurement equipment for electronics; that division was spun off to form Keysight. Since then, the company has continued to expand into pharmaceutical, diagnostics & clinical, and academia & government markets. Wikipedia
About Agilent Technologies Inc
CEOპადრეგ მაკდონელ
Employees18,2 ათ.
Founded1999
Headquartersსანტა-კლარა, კალიფორნია, ამერიკის შეერთებული შტატები
SectorHealth care
Analyst ratings
Based on 14 analysts giving stock ratings to A in the past 3 months
Strong buy
Buy
11
Hold
3
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for A in the last 3 months.
Highest
Current 170,54 US$
195,00 US$ (+14,34%)
Average
179,86 US$ (+5,46%)
Lowest
150,00 US$ (-12,04%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Ryskin
Bank of America Securities
Buy
Maintained
190,00 US$
+11,4%
10/09/2026
Luke Sergott
Barclays
Buy
Maintained
195,00 US$
+14,3%
10/07/2026
Eve Burstein
Bernstein
Buy
Maintained
180,00 US$
+5,5%
09/25/2026
Evie Koslosky
Goldman Sachs
Buy
Maintained
185,00 US$
+8,5%
09/20/2026
John Dunigan
Jefferies
Hold
Maintained
181,00 US$
+6,1%
09/17/2026
Blayne Curtis
Jefferies
Hold
Maintained
155,00 US$
-9,1%
09/11/2026
Unknown Analyst
UBS
Hold
Initiated
165,00 US$
-3,2%
09/08/2026
Doug Schenkel
UBS
Hold
Initiated
165,00 US$
-3,2%
09/09/2026
Tycho Peterson
Jefferies
Hold
Maintained
155,00 US$
-9,1%
09/02/2026
Kallum Titchmarsh
Morgan Stanley
Buy
Maintained
175,00 US$
+2,6%
09/01/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
180,00 US$
+5,5%
08/30/2026
Evan Stampler
Wells Fargo
Buy
Maintained
180,00 US$
+5,5%
08/28/2026
David Westenberg
Piper Sandler
Hold
Reiterated
150,00 US$
-12%
08/27/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
172,00 US$
+0,9%
08/27/2026
Dan Leonard
RBC Capital
Buy
Maintained
185,00 US$
+8,5%
08/26/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
180,00 US$
+5,5%
08/27/2026
Casey Woodring
J.P. Morgan
Buy
Maintained
190,00 US$
+11,4%
08/27/2026
Patrick B Donnelly
Citi
Buy
Maintained
190,00 US$
+11,4%
08/27/2026
Sidharth Sahoo
HSBC
Buy
Maintained
165,00 US$
-3,2%
06/03/2026
Michael Polark
Wolfe Research
Hold
Initiated
135,00 US$
-20,8%
06/01/2026
Brandon Couillard
Wells Fargo
Buy
Maintained
160,00 US$
-6,2%
05/28/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
156,00 US$
-8,5%
05/26/2026
Jack Meehan
Nephron
Buy
Upgraded
145,00 US$
-15%
03/26/2026
Last report
26 აგვ. 2026
Fiscal period
Q3 2026
1,62 US$ / 1,49 US$
+9,01%beat
Revenue / Est. (USD)
1,88 მლრდ. / 1,84 მლრდ.
+1,98%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ოქტ. 2025
იან. 2026
აპრ. 2026
ივლ. 2026
Revenue
1,86 მლრდ.
1,80 მლრდ.
1,84 მლრდ.
1,88 მლრდ.
Cost of goods sold
893,00 მლნ.
847,00 მლნ.
842,00 მლნ.
835,00 მლნ.
Cost of revenue
893,00 მლნ.
847,00 მლნ.
842,00 მლნ.
835,00 მლნ.
Research and development expenses
117,00 მლნ.
117,00 მლნ.
126,00 მლნ.
113,00 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
382,00 მლნ.
423,00 მლნ.
432,00 მლნ.
450,00 მლნ.
Operating expense
499,00 მლნ.
540,00 მლნ.
558,00 მლნ.
563,00 მლნ.
Total operating expenses
1,39 მლრდ.
1,39 მლრდ.
1,40 მლრდ.
1,40 მლრდ.
Operating income
469,00 მლნ.
411,00 მლნ.
435,00 მლნ.
480,00 მლნ.
Other non operating income
45,00 მლნ.
3,00 მლნ.
9,00 მლნ.
3,00 მლნ.
EBT including unusual items
442,00 მლნ.
364,00 მლნ.
408,00 მლნ.
444,00 მლნ.
EBT excluding unusual items
492,00 მლნ.
404,00 მლნ.
429,00 მლნ.
469,00 მლნ.
Income tax expense
8,00 მლნ.
59,00 მლნ.
69,00 მლნ.
82,00 მლნ.
Effective tax rate
1,81%
16,21%
16,91%
18,47%
Other operating expenses
-
-
-
-
Net income
434,00 მლნ.
305,00 მლნ.
339,00 მლნ.
362,00 მლნ.
Net profit margin
23,32%
16,96%
18,47%
19,28%
Earnings per share
1,59
1,36
1,49
1,62
Interest and investment income
17,00 მლნ.
15,00 მლნ.
13,00 მლნ.
15,00 მლნ.
Interest expense
-27,00 მლნ.
-25,00 მლნ.
-25,00 მლნ.
-29,00 მლნ.
Net interest expenses
-10,00 მლნ.
-10,00 მლნ.
-12,00 მლნ.
-14,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
540,00 მლნ.
478,00 მლნ.
502,00 მლნ.
546,00 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები